Skip to main navigation
Skip to search
Skip to main content
Research Profiles at Washington University School of Medicine Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Peripheral T-cell lymphoma: are all patients high risk?
Lauren Shea,
Neha Mehta-Shah
Section of Medical Oncology
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
2
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Peripheral T-cell lymphoma: are all patients high risk?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
High Risk
100%
Peripheral T-cell Lymphoma
100%
Minimal Residual Disease
25%
5-year Survival
12%
Positron Emission Tomography-computed Tomography (PET-CT)
12%
Non-Hodgkin Lymphoma
12%
Risk Stratification
12%
Treatment Strategy
12%
Heterogeneous Groups
12%
Registry Data
12%
Disease Dynamics
12%
Molecular Biomarkers
12%
Anaplastic Large Cell Lymphoma
12%
Doxorubicin
12%
Prognostic Score
12%
Cyclophosphamide
12%
Angioimmunoblastic T-cell Lymphoma
12%
Biomarker Imaging
12%
Registry Study
12%
Emerging Tools
12%
T Follicular Helper Cells
12%
Cell Lymphoma
12%
Dynamic Risk Stratification
12%
Mature T-cell Neoplasm
12%
Medicine and Dentistry
Peripheral T-Cell Lymphoma
100%
Risk Stratification
25%
Minimal Residual Disease
25%
Biological Marker
12%
Neoplasm
12%
Overall Survival
12%
T Cell
12%
Non-Hodgkin Lymphoma
12%
Tomography
12%
Anaplastic Large Cell Lymphoma
12%
Prognostication
12%
Doxorubicin
12%
Cyclophosphamide
12%
Vincristine
12%
Angioimmunoblastic T-Cell Lymphoma
12%
T Follicular Helper Cell
12%